Several research studies have recently reported that abnormal amplification of the MDM2 gene in neuroblastoma and glioblastoma causes the protein degradation of the p53 gene that initiates the high progression of tumor tissue in brain cancer [48]. Here, TP53 is linked to neuroblastoma.